Specialised pro-resolving mediators of inflammation in inflammatory arthritis
详细信息 查看全文
- 作者：Anne E. Bardena ; anne.barden@uwa.edu.au" class="auth_mail" title="E-mail the corresponding author ; Mahin Moghaddamib ; c ; Emilie Masa ; Michael Phillipsd ; Leslie G. Clelandb ; c ; 1 ; Trevor A. Moria ; 1
- 关键词：SPM ; specialised pro-resolving mediators ; n-3FA ; n-3 long chain polyunsaturated fatty acids ; 18-HEPE ; 18-hydroxyeicosapentaenoic acid ; 17-HDHA ; 17-hydroxydocosahexaenoic acid ; 10S ; 17S-DHDHA ; 10S ; 17S-dihydroxydocosahexaenoic acid ; MaR-1 ; maresin-1 ; 14-HDHA ; 14-hydroxydocosahexaenoic acid ; AA ; arachidonic acid ; DHA ; docosahexaenoic acid ; EPA ; eicosapentaenoic acid ; RvE1 ; resolvin E1 ; RvE2 ; resolvin E2 ; RvE3 ; resolvin E3 ; 18R-RvE3 ; 18R-resolvin E3 ; RvD1 ; resolvin D1 ; 17R-RvD1 ; 17R resolvin D1 ; Rv
- 刊名：Prostaglandins, Leukotrienes and Essential Fatty Acids
- 出版年：2016
- 出版时间：April 2016
- 年：2016
- 卷：107
- 期：Complete
- 页码：24-29
- 全文大小：517 K
文摘
- •
Plasma SPM are elevated in arthritis compared with controls taking n-3FA.
- •
Conversion to E- and D-series SPM was greater in SF than plasma of arthritis patients.
- •
Synovial fluid RvE2 was negatively associated with pain score in arthritis patients.